Category: Anticoagulation
-
-
GAME-CHANGERS IN FOCUS، A Quiz on Landmark Trials of 2024
April 15, 2025Quiz of 2024 landmark Trials
-
-
-
5th Umbrella: Antithrombotic Therapy in Venous Thromboembolism
March 25, 2025Antithrombotic Therapy in VTE
-
5th Umbrella: Antithrombotic Therapy in Atrial Fibrillation
March 25, 2025Antithrombotic Therapy in AF
-
5th Umbrella: Antithrombotic Therapy in Chronic Coronary Syndrome
March 25, 2025Antithrombotic Therapy in CCS
-
5th Umbrella: Antithrombotic Therapy in Acute Coronary Syndrome
March 25, 2025Antithrombotic Therapy in ACS
-
-
-
-
Daily Cardiology 5th Umbrella: The Art of Antithrombotic Therapy In Daily Cardiovascular Practice
January 26, 20255th Umbrella: Antithrombotic Therapy
-
Cardiosignal 83, Antithrombotic therapy Post PCI in CCS patients with an indication for OAC
January 19, 2025Cardiosignal 83
-
-
-
-
-
Case Discussion 122: Antiarrhythmic and Anticoagulant Therapy After AF Ablation
January 1, 2025Case Discussion 122: Medications after AF Ablation
-
Case Discussion 120: VTE prophylaxis in a CAD patient on ASA, after TKA
December 30, 2024Case Discussion 120: VTE prophylaxis
-
Cardiosignal 79, Antithrombotic therapy post PCI in CCS patients with an indication for OAC
November 10, 2024Cardiosignal 79
-
-
-
34th ESC 2024 Congress Coverage: De-escalation to ticagrelor monotherapy vs. 12 months of dual antiplatelet therapy
October 16, 202434th ESC 2024: Ticagrelor monotherapy vs. dual antiplatelet therapy
-
-
20th ESC 2024 Congress Coverage: OCEANIC-AF Trial
September 30, 202420th ESC 2024: OCEANIC-AF Trial
-
-
-
-
-
-
Daily Cardiology Symposium 1403: Antithrombotics in Preventive Cardiology
July 17, 2024DCS 1403: Antithrombotics
-
-
Case Discussion 117 Answer: VTE prophylaxis in acutely ill hospitalized medical patients
June 19, 2024Case Discussion 117 Answer: VTE prophylaxis in hospitalized patients
-
-
Save The Date: Hypertension and Hyperlipidemia Academy, No. 16
May 7, 2024Save The Date: 15th H&H Academy
-
-
Case Discussion 111 Answer: Perioperative Management of Antiplatelet Medications in CCS Patients Undergoing CABG
April 6, 2024Case Discussion 111 Answer: Antiplatelet therapy before CABG in CCS patients
-
Cardiology Online Grand Round: The Art of Optimal Medical Therapy for Heart Failure
April 1, 2024Cardiology Online Grand Round: OMT in HF
-
Light Rounds Volume 7: Elderly gentleman with HTN, ICMP and SCAF
March 16, 2024Light Round Volume 7: Approach to a patient with subclinical AF
-
-
-
Impact: Contemporary Management and Outcomes of Patients With High-Risk Pulmonary Embolism
January 20, 2024mpact: High Risk PE
-
Impact: Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention
January 20, 2024Impact: SAPT 1 year after PCI
-
Case Discussion 109 Answer: GI protection in patients on single antiplatelet therapy
January 16, 2024Case Discussion 109 Answer: GI protection in SAPT
-
-
-
-
Case Discussion 98 Answer: Long term anticoagulation after cerebral venous sinus thrombosis
November 27, 2023Case Discussion 98 Answer: Anticoagulation after cerebral venous sinus thrombosis
-
AHA23 Congress Coverage: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation: ARTESIA trial
November 18, 2023AHA23 Congress Coverage: Apixaban in subclinical AF (ARTESIA)
-
Light Rounds Volume 6: Elderly gentleman with T2D, CAD and foot ulcer
October 15, 2023Light Round Volume 6: Approach to a patient with an ischemic foot ulcer
-
Case Discussion 99: Choosing P2Y12 inhibitors in STEMI patients treated with Fibrinolytics and undergoing PCI
October 2, 2023Case Discussion 99: P2Y12 choice for PCI after fibrinolytic Tx
-
-
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of endocarditis
September 11, 2023ESC 2023: New Endocarditis Guideline
-
-
-
-
-
-
-
-
-
Impact: Early versus Later Anticoagulation for Stroke with Atrial Fibrillation
August 12, 2023Impact: Anticoagulation in AF and stroke
-
Daily Cardiology Symposium 1402 Day 2 Panel 4
July 25, 2023Infective Endocarditis and Prosthetic Valve Malfunction
-
Daily Cardiology Symposium 1402 Day 2 Panel 3
July 25, 2023Chronic Limb-Threatening Ischemia and Acute Aortic Syndromes
-
-
Daily Cardiology Symposium 1402 Day 1 Panel 3
July 25, 2023Acute Coronary Syndrome and Acute Chest Pain
-
-
-
NEJM Knowledge plus Case Discussion
July 24, 2023a Case Discussion from NEJM Knowledge plus service
-
-
-
-
-
Light Rounds Volume 3: elderly gentleman with ICMP and LV thrombus
June 6, 2023Light Rounds 3: LV thrombus
-
-
-
-
Young Cardiologist Award 1402 Introduction video by Dr. Aminian
May 18, 2023YCA 1402 introduction by Dr. Aminian
-
-
Young Cardiologist Award 1402 Introduction video by Dr. Shishehbor
May 13, 2023YCA 1402 introduction by Dr. Shishehbor
-
Save the Date: American College of Cardiology 2023 Congress Coverage
May 1, 2023Save the Date: ACC.23 congress coverage
-
Young Cardiologist Award 1402 Introduction video by A. Yahyavi, MD
April 29, 2023YCA 1402 introduction by Dr. Yahyavi
-
-
-
Daily Cardiology Symposium 1402 Save The Date poster Motion
April 10, 2023DCS 1402 Save The Date Poster Motion
-
-
-
-
-
Impact: Management of ACS in older adults, an AHA statement
December 24, 2022Impact: ACS in the elderly
-
Case Discussion No. 68 Answer: anticoagulation in pregnancy
December 19, 2022Case Discussion No. 68 Answer
-
-
-
Impact: Dual antiplatelet therapy with Ticagrelor and graft failure after coronary artery bypass grafting
November 2, 2022Dual antiplatelet Tx. with Ticagrelor and graft failure after CABG
-
-
Vision: Vol. 3, Antithrombotic therapy for surgical bioprosthetic valves and valve repair
September 18, 2022Vision, 3rd episode: antithrombotic Tx. in bioprosthetic valves and valve repair
-
-
-
-
Save the date: European Society of Cardiology 2022 congress coverage
August 22, 2022Save the date: ESC 2022 congress coverage
-
-
-
-
-
-
Cardio-Signal 51
August 5, 2022Management of antithrombotic therapy after prosthetic valve implantation
-
-
-
-
-
-
Daily Cardiology Symposium 1401, Day 2 Panel 4: Valvular heart disease
June 26, 2022DCS 1401: Valvular heart disease
-
-
-
-
Daily Cardiology Symposium 1401, Day 1 Panel 4: Peripheral vascular diseases
June 26, 2022DCS 1401: Peripheral vascular diseases
-
Daily Cardiology Symposium 1401, Day 1 Panel 3: Venous thromboembolism (VTE) prophylaxis
June 26, 2022DCS 1401: Venous thromboembolism (VTE) prophylaxis
-
Daily Cardiology Symposium 1401, Day 1 Panel 2: Revascularization in CAD
June 26, 2022DCS 1401: Revascularization in CAD
-
-
-
-
-
Daily Cardiology Symposium 1401 faculty and executive committee motion
May 14, 2022DCS 1401 faculty and executive committee motion
-
Save the date: Hypertension and Hyperlipidemia Academy, 8th
May 10, 2022Save the date: 8th H&H Academy
-
American College of Cardiology (ACC) congress 2022 landmark trials review
May 3, 2022ACC 2022 congress coverage
-
-
At a glance: Ticagrelor and prevention of recurrent thrombotic events in CCS
April 23, 2022Ticagrelor and secondary prevention in CCS
-
-
Daily Cardiology Symposium 1401 faculty and executive committee
April 18, 2022DCS 1401 faculty and executive committee
-
-
-
-
-
-
-
Save the date: Cardiometabolic grand round 6
March 2, 2022Save the date: the 6th cardiometabolic grand round
-
-
-
-
-
which prophylaxis? for whom? VTE prophylaxis panel discussion
January 26, 2022Case-based panel discussion on VTE prophylaxis
-
Save the date: which prophylaxis? for whom? VTE prophylaxis panel discussion
January 19, 2022Case-based panel discussion on VTE prophylaxis
-
Save the date: A glimpse of DCS 1400 and invitation to DCS 1401
January 7, 2022DCS 1400 review and what’s coming next
-
At a Glance: Approach to Ticagrelor-induced Dyspnea
January 2, 2022Managing dyspnea induced by Ticagrelor
-
Umbrella Heart and Stroke: session 4, Antithrombotic therapy for the secondary prevention of stroke
January 2, 2022Umbrella H&S: session 4, secondary prevention of stroke
-
Umbrella Heart and Stroke: session 3, Atrial fibrillation screening
January 2, 2022Umbrella H&S: session 3, AF screening
-
Umbrella Heart and Stroke: session 2, carotid stenosis and stroke
January 2, 2022Umbrella H&S: session 2, carotid stenosis
-
Umbrella Heart and Stroke: session 1, detecting & managing patients with PFO
January 2, 2022Umbrella H&S: session1, PFO
-
Rivaroxaban vs Apixaban in major ischemic or hemorrhagic events in AF
December 29, 2021Rivaroxaban vs Apixaban in AF
-
-
At a glance: preventing cardiovascular thrombotic event after ACS
December 21, 2021Ticagrelor in preventing post-ACS thrombotic events
-
HeartCast 1: practical approach to the treatment of HFrEF
December 15, 2021The first HeartCast: HFrEF management
-
-
-
Ticagrelor Hub: when to use and which dose?
November 28, 2021The dosage and indications of Ticagrelor
-
Cardiometabolic Grand round, Session 5
November 21, 2021The 5th session of Cardiometabolic grand round
-
Save the date: Umbrella: Heart and Stroke
November 14, 2021The second program of Umbrella series: Heart and Stroke
-
Save the date: Cardiorenal Metabolic Crossroads: Case-based Panel Discussion, 4th Session
November 1, 2021The 4th session of Cardiorenal metabolic crossroads program
-
-
Save the date: Late-breaking Science in Cardiovascular disease prevention
October 19, 2021ESC 2021 cardiovascular prevention guideline lectures and discussion
-
Save the date; Cardiorenal Metabolic Crossroads: case-based panel discussion
October 10, 2021The second session of Cardiorenal metabolic crossroads program
-
-
-
-
Cardio-Watch Podcast: Episode 7, ESC 2021 special
September 20, 2021The seventh episode of Cardio-Watch: ESC 2021
-
-
Therapeutic anticoagulation with Heparin in critically and non-critically ill patients with COVID-19
September 17, 2021The role of Heparin in the management of thrombosis in COVID-19
-
-
-
-
-
-
-
-
-
-
-
From optimal medical therapy to revascularization in CCS
August 14, 2021Choosing the best therapeutic strategy in CCS
-
Antithrombotic lighthouse, Cases and Faces: antithrombotic therapy in CAD
August 14, 2021Antithrombotic regimens in CAD
-
-
Save the date: The first Umbrella event: chronic coronary syndrome
August 8, 2021First Umbrella session: CCS
-
Finding the optimal thromboprophylaxis regimen in patients with COVID-19
August 4, 2021Preventing thromboembolic events in COVID-19
-
-
Save the date: Anti-thrombotic lighthouse: navigating a new path to CAD management
August 2, 2021Anti-thrombotic lighthouse, 3rd session: anti-thrombotic therapy in CAD Cardio Calendar
-
-
Save the date: Finding the optimal thromboprophylaxis regimen in patients with COVID-19
July 31, 2021thromboprophylaxis in COVID-19
-
Save the date: Umbrella, Focused cardiology forums
July 27, 2021The first session of Umbrella series
-
Tailored Antithrombotic therapy for CCS patients
July 25, 2021Best individual antithrombotic strategy in CCS
-
-
Save the date: Anti-Thrombotic Lighthouse (2nd session)
July 14, 20212nd session of Anti-Thrombotic Lighthouse: antiplatelet therapy in CCS
-
Marking the antiplatelet therapy maze in ACS
July 12, 2021How to prevent atherosclerotic cardiovascular events
-
Safety and Efficacy of different antithrombotic strategies after TAVI
July 11, 2021Post-TAVI antithrombotic strategies
-
Save the date: Anti-Thrombotic Lighthouse (1st session)
June 26, 20211st session of Anti-Thrombotic Lighthouse: antiplatelet therapy in ACS
-
DiaBeat: The Beating Heart of Diabetes (6th session)
June 24, 20216th Diabetes Masterclass for Cardiologists
-
Cardiometabolic Grand Round: 4th session
June 24, 2021Guideline-directed cardiovascular evaluations before surgery
-
DCS 1400: session 8, Valvular Heart disease
June 16, 2021The eighth panel of DCS 1400: Valvular Heart disease
-
-
-
-
-
Cardio-Watch podcast: Episode 3, Atrial fibrillation and Flutter
June 13, 2021The Third episode of Cardio-Watch: AF
-
Left Atrial Appendage Occlusion to prevent Stroke
June 9, 2021Preventing Stroke by surgical LA Appendage Occlusion
-
A review on four landmark anti-platelet therapy trials
June 1, 2021The latest updates on anti-platelet therapy from 4 important trials
-
Aspirin vs Clopidogrel for chronic maintenance monotherapy after PCI
May 20, 2021The comparison of Clopidogrel and Aspirin monotherapy after PCI (HOST-EXAM trial)
-
Impact: DAPT vs. Aspirin in patients with stroke or TIA
May 16, 2021A recent meta-analysis about antiplatelet therapy in stroke
-
The evolution of antiplatelet therapy in CAD: a 45 year journey
May 10, 2021A brief history of anti-platelet therapy in CAD
-
-
-
Impact: No-LVT trial
April 13, 2021Comparative study of oral anticoagulation in left ventricular thrombi
-
Daily Cardiology Symposium 1400. Concise, Precise, Practical
April 10, 2021Case-based review of common cardiovascular practice The digital experience
-
-
CardioPoint (11): Antithrombotic therapy in patients with AF treated with OAC undergoing PCI
March 11, 2021Quick Review of ACC 2020 Expert Consensus Pathway of Antithrombotic Management
-
Save the date: Daily Cardiology Symposium 1400
March 11, 2021Case-based review of common cardiovascular practice
-
An introduction to daily cardiology academy symposium; a digital learning opportunity
February 26, 2021Invitation for attending the symposium by executive directors
-
Introduction: Evolution of DOACs and their place in Guidelines
January 21, 2021A brief report of Guidelines mentioned DOACs place in practice
-
Save the date: To DOAC or Not To DOAC
January 21, 2021Rapid review of oral Anticoagulation practice in different clinical scenarios
-
10th Case: Drug Drug Interactions
January 21, 2021DOACs important interactions in clinical practice
-
To DOAC or Not to DOAC
January 21, 2021Rapid review of oral anticoagulation practice in different clinical scenarios
-
-
-
Seventh Case: Thrombocytopenia
January 21, 2021Any Concerns for OACs Use in Patients with Thrombocytopenia
-
Sixth Case: Hepatic Impairment
January 21, 2021OAC of choice in patients with hepatic impairment, any difference between DOACs?
-
-
Forth Case: Extreme Body Weights
January 21, 2021OAC choice in patients with obesity or low body weights, any role for DOACs?
-
Third Case: AF & Artificial Heart Valves
January 21, 2021OAC of choice in patients with artificial heart valves
-
Second Case: Cancer associated VTE
January 21, 2021Anticoagulation of choice in patients with cancer, the importance of DDI
-
First Case: Elective PCI and AF
January 21, 2021Antithrombotic regimen of choice in patients with AF undergoing elective PCI
-
Save the date: 1st Daily Cardiology Symposium
January 19, 2021Case-based review of common cardiometabolic practice
-
What is new in the 2020 ESC Guideline for the diagnosis and management of Atrial Fibrillation
December 7, 2020Part Four: LSM, bleeding management, pregnancy, POAF, sex related differences
-
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
December 3, 2020Part Three: Cardioversion, rhythm control, catheter ablation Long term anti arrhythmic drugs
-
Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor+ASA for Prevention of Stroke and Death (THALES Trial)
November 30, 2020The effects of Ticarelor+ASA in Acute Stroke
-
-
-
Rivaroxaban in Patients with AF and a Bioprosthetic Mitral Valve
November 26, 2020The findings of RIVER trial
-
Save the Date: Antithrombotic Therapy to Prevent Cardiovascular Events in Type 2 Diabetes
November 4, 2020Comprehensive talk on DAPT vs Low dose Rivaroxaban in patients with T2DM and CVD
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
November 3, 2020Part Two: Prevention of thromboembolic events Patients with AF and an ACS, PCI or CCS
-
Save the date: ESC 2020 Congress Coverage What is new on NSTE-ACS Guideline: a panel discussion
October 31, 2020Brief Discussion on the New ESC Guideline on NSTE-ACS
-
Save the date: Paradigm Shift in Treating Intermediate Risk Pulmonary Embolism
October 29, 2020Concise Talk on Intermediate Risk Pulmonary Embolism, update by an expert in the field
-
Paradigm Shift in Treating Intermediate Risk Pulmonary Embolism
October 29, 2020Concise Talk on Intermediate Risk Pulmonary Embolism, update by an expert in the field
-
Save the date: VTE Prophylaxis in Patients with COVID-19
October 20, 2020Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)
-
VTE Prophylaxis in Patients with COVID-19
October 19, 2020Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
October 3, 2020Updated changes in AF ESC 2020 compared to previous Guidelines (Part one)
-
ESC 2020 Congress Coverage What is new on NSTE-ACS Guideline: a panel discussion
October 2, 2020Brief Discussion on the New ESC Guideline on NSTE-ACS
-
-
Ground-breaking research from ESC Congress 2020 (23)
September 16, 2020Part Twenty-three: Trial Review, ELDERCARE-AF
-
Ground-breaking research from ESC Congress 2020 (18)
September 16, 2020Part Eighteen: Trial Review, HOME-PE
-
Case Discussion (30)
September 12, 2020Optimal Antithrombotic Regimen Early & Late After Discharge in Patients Presenting With STEMI
-
-
Save the date: Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
Impact: adding Ticagrelor to Aspirin in CABG patients
September 1, 2020The findings of POPular CABG trial
-
Impact: Aspirin with or without Clopidogrel after TAVI
August 31, 2020The findings of POPULAR TAVI trial
-
CardioPoint (9): Once vs. twice-daily NOACs and adherence considerations
August 22, 2020A Brief Description on Practical Points in Anticoagulation
-
Save the date: Shielding the Brain From Stroke
August 20, 2020A case based discussion on optimization of antithrombotic therapy in patients with ischemic stroke
-
Shielding the Brain From Stroke
August 20, 2020A case based discussion on optimization of antithrombotic therapy in patients with ischemic stroke
-
Save the date: Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion
August 18, 2020Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease
-
Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion
August 18, 2020Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease
-
Pharmacological approach to ACS management in patients on DOAC
August 12, 2020Challenges on fibrinolytic therapy and primary PCI issues in admitted ACS patients on DOACs
-
-
-
-
Save the date: Cardiometabolic Care Network
July 16, 2020Interprofessional Collaboration Practice in Risk Management of ASCVD
-
Cardiometabolic Care Network
July 16, 2020Interprofessional Collaboration Practice in Risk Management of ASCVD
-
-
-
Dosage Modification of DOACs in Different Clinical Scenarios & in Renal Impairment
July 3, 2020Algorithmic approach to DOACs Dose Adjustment in CKD
-
-
Low-dose Rivaroxaban in Management of PAD Patients
June 23, 2020Insights from COMPASS & VOYAGER Trials
-
-
Low-dose Rivaroxaban in Management of Post-Revascularized CAD Patients
June 23, 2020Insights from COMPASS-PCI & COMPASS-CABG Trials
-
At a glance; How dual pathway found its way into ESC guidelines?
June 7, 2020Rivaroxaban on board for CCS
-
-
-
-
-
-
COVID-19 and thrombotic or thromboembolic disease: implication for prevention, antithrombotic therapy, and follow up
May 12, 2020Antithrombotic challenge in patients with COVID-19; focus on JACC State of ART review
-
Case Discussion (5)
May 4, 2020Evidenced based discussion on routine cases of cardiology in clinical practice - Antithrombotic Therapy in CCS
-
Save the date: COVID-19 and thrombotic or thromboembolic disease: implication for prevention, antithrombotic therapy, and follow up
May 3, 2020Antithrombotic challenge in patients with COVID-19; focus on JACC State of ART review
-
Cardiovascular medication interactions with antiviral agents used for COVID-19
March 3, 2020Quick review of CV medications interactions with medications used for COVID-19
-
Cardiovascular medication interactions with antiviral agents used for COVID-19: Second Update
March 3, 2020Quick review of CV medications interactions with medications used for COVID-19
-
-
CardioPoint (7): Selecting appropriate NOAC
February 28, 2020A Brief Description on Practical Points in Anticoagulation
-
Predicting the Risk of Post-stroke Atrial Cardiopathy
February 27, 2020An interim analysis from ACARDIA trial
-
OACs vs. antiplatelet or placebo for stroke prevention in patients with HF and sinus rhythm
February 3, 2020A meta-analysis of RCTs
-
Association of Anticoagulation Therapy with the Risk of Fracture in AF Patients
January 21, 2020The findings of a recent study
-
Cardiology Close-Up (10)
January 2, 2020Antithrombotic Therapy in Patients with Chronic Coronary Syndrome and in Sinus Rhythm
-
-
Case Discussion (1)
December 4, 2019Evidenced based discussion on routine cases of cardiology in clinical practice Appropriate OAC choice in AF
-
AF after Non-Cardiac Surgery Increases the Risk of Stroke
November 13, 2019A meta-analysis of post-operative AF studies
-
Rivaroxaban vs. Vit K Antagonist in Antiphospholipid Syndrome
November 12, 2019Rivaroxaban versus warfarin in APS
-
Antithrombotic treatment after CABG
November 12, 2019A recent meta-analysis on post-CABG Antithrombotic therapy
-
Daily Cardiology Cath-Conference: Case no. 2
October 23, 2019The second case of Daily Cardiology Cath-Conference
-
CardioPoint (5): NOACs in CKD
October 23, 2019A Brief Description on Practical Points in Anticoagulation
-
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease
October 15, 2019The findings of EXCEL Trial
-
Ticagrelor with or without Aspirin in High-Risk patients after PCI
September 28, 2019The findings of TWILIGHT Trial
-
-
AF Patients on NOACs Undergoing Elective PCI or Angiography: When to Hold?
September 3, 2019Pre-procedural management of DOACs
-
Pantoprazole in Patients Receiving Rivaroxaban and/or Aspirin
August 24, 2019The findings of COMPASS trial
-
OAC Monotherapy in Patients with Stable CAD and Non-valvular AF
August 20, 2019OACs in Stable CAD and AF
-
CardioPoint (3): NOACs in Elderly
August 19, 2019A Brief Description on Practical Points in Anticoagulation
-
CardioPoint (2) – NOAC Monitoring, Do NOACs Need Monitoring?
June 19, 2019A Brief Description on Practical Points in Anticoagulation
-
Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half
May 29, 2019The findings of REASTART Trial
-
Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or TIA
May 25, 2019DAPT after ischemic stroke or TIA
-
-
Cardiology Close-Up (1)
March 7, 2019Management of Antithrombotic Therapy in AFib Patients Undergoing PCI
-
-
